Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) to Post FY2026 Earnings of ($5.55) Per Share, Zacks Research Forecasts
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research issued their FY2026 earnings per share estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, March 7th. Zacks Research analyst A. Chakraborty anticipates that the biopharmaceutical company will post earnings of ($5.55) per share for the year. The consensus estimate […]
More Stories
CCM Investment Advisers LLC Trims Stock Position in Walmart Inc. (NYSE:WMT)
CCM Investment Advisers LLC trimmed its holdings in Walmart Inc. (NYSE:WMT – Free Report) by 1.4% in the 4th quarter,...
The Lawsuits Targeting President-elect Trump
By Sam Dorman the_lawsuits_targeting_presidentelect_trumpDownload… Source
Atlas Brown Inc. Buys 170 Shares of Fidelity MSCI Information Technology Index ETF (NYSEARCA:FTEC)
Atlas Brown Inc. increased its stake in shares of Fidelity MSCI Information Technology Index ETF (NYSEARCA:FTEC – Free Report) by...
Atlas Brown Inc. Has $387,000 Stock Position in iShares MSCI USA Min Vol Factor ETF (BATS:USMV)
Atlas Brown Inc. lessened its stake in shares of iShares MSCI USA Min Vol Factor ETF (BATS:USMV – Free Report)...
Bruce G. Allen Investments LLC Purchases 869 Shares of Capital Group Dividend Value ETF (NYSEARCA:CGDV)
Bruce G. Allen Investments LLC grew its position in Capital Group Dividend Value ETF (NYSEARCA:CGDV – Free Report) by 12.3%...
abrdn Bloomberg All Commodity Strategy K-1 Free ETF (NYSEARCA:BCI) Shares Bought by Bruce G. Allen Investments LLC
Bruce G. Allen Investments LLC increased its position in abrdn Bloomberg All Commodity Strategy K-1 Free ETF (NYSEARCA:BCI – Free...